NITROXOLIN-MIP 250mg capsules medication leaflet

J01XX07 nitroxoline • Antiinfectives for systemic use | Other antibacterials

Nitroxolinum is an antibiotic used to treat urinary tract infections caused by sensitive bacteria. This medication works by inhibiting bacterial DNA synthesis, thereby preventing the multiplication of pathogenic microorganisms.

Nitroxolinum is effective against a wide range of bacteria, including Escherichia coli, Proteus, and Klebsiella. It is primarily used for acute and chronic urinary tract infections, such as cystitis and pyelonephritis.

The drug is generally well-tolerated but may cause side effects such as nausea, vomiting, or allergic reactions. It is important to follow the prescribed dosage to avoid the development of bacterial resistance.

Nitroxolinum is not recommended during pregnancy or breastfeeding unless the benefits outweigh the risks. Consult your doctor before use.

General data about NITROXOLIN-MIP 250mg

Substance: nitroxoline

Date of last drug list: 02-10-2013

Commercial code: W59990001

Concentration: 250mg

Pharmaceutical form: capsules

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CHEPHASAAR CHEM.-PHARM. FABRIK GMBH - GERMANIA

Holder: MIP PHARMA GMBH - GERMANIA

Number: 13379/2020/01

Shelf life: 2 years

Pharmaceutical forms available for nitroxoline